Dishman Carbogen (DCAL)
TURNAROUNDFairStock Score: 10/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹174.6 |
| Market Cap | ₹2,744.64 Cr |
| P/E Ratio | 20.81 |
| ROCE | 2.42% |
| ROE | -1.02% |
| Dividend Yield | 0% |
| Profit Growth | -381.96% |
| Debt/Equity | 0.4 |
| Sales Growth | 5.49% |
| Promoter Holding | 59.32% |
| 52-Week Range | ₹128.5 — ₹321.95 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹253.34 |
Dishman Carbogen trades with a P/E ratio of 20.81, ROCE of 2.42%, ROE of -1.02%, profit growth of -381.96%, debt-to-equity of 0.4. The FairStock Score of 10/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer